Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Septic subdeltoid bursitis.

E K Chartash1, P K Good, E S Gould

  • 1Division of Rheumatology and Allergy-Clinical Immunology, North Shore University Hospital, Manhasset, NY 11030.

Seminars in Arthritis and Rheumatism
|August 1, 1992
PubMed
Summary

Septic subdeltoid bursitis, often linked to bacteremia or trauma, presents with severe inflammation. Prompt, aggressive treatment is crucial for favorable outcomes in this shoulder joint infection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessments of fatigue and disease activity in patients with systemic lupus erythematosus enrolled in the Phase 2 clinical trial with blisibimod.

Lupus·2016
Same author

Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study.

Annals of the rheumatic diseases·2015
Same author

Age-related variation in limb bone diaphyseal structure among Inuit foragers from Point Hope, northern Alaska.

Archives of osteoporosis·2014
Same author

A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC study.

Annals of the rheumatic diseases·2014
Same author

Adalimumab plus methotrexate or standard therapy is more effective than methotrexate or standard therapies alone in the treatment of fatigue in patients with active, inadequately treated rheumatoid arthritis.

Clinical and experimental rheumatology·2008
Same author

Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended study.

Annals of the rheumatic diseases·2005

Area of Science:

  • Orthopedics
  • Infectious Diseases
  • Rheumatology

Background:

  • Septic bursitis is a joint infection that can affect various bursae.
  • Subdeltoid bursitis, an infection of the bursa in the shoulder, is rare.

Observation:

  • This study details four new cases of septic subdeltoid bursitis and reviews six prior cases.
  • Etiologies included bacteremia, trauma, and immune incompetence.
  • Compared to other septic bursitis types, subdeltoid bursitis showed greater inflammation and required advanced diagnostics.

Findings:

  • Septic subdeltoid bursitis necessitates more aggressive diagnostic and therapeutic approaches.
  • Microbiology and clinical presentations were analyzed across all reported cases.
  • Appropriate and timely interventions led to positive patient outcomes.

Implications:

  • Highlights the severity and specific management needs of septic subdeltoid bursitis.
  • Emphasizes the importance of early diagnosis and aggressive treatment for shoulder joint infections.
  • Contributes to understanding rare infectious joint conditions and optimizing patient care strategies.

Related Experiment Videos